Diethylphosphonoaceticum acidum CAS 3095-95-2 Puritas >99.5% (HPLC)

Description:

Nomen chemicum: Diethylphosphonoaceticum acidum

CAS: 3095-95-2

Puritas: >99.5% (HPLC)

Aspectus: Colorless Liquid

Afatinib Dimaleate (CAS: 850140-73-7)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum Diethylphosphonoaceticum acidum
Synonyma 2-(Diethoxyphosphoryl) Acidum aceticum;(Diethoxyphosphinyl) Acidum aceticum;Diethyl Carboxymethylphosphonate;NSC 272281
CAS Number 3095-95-2
CATTUS Number RF-PI2024
Stock Status In Stock, Productio Capacitas 30MT/Mense
Formulae hypotheticae (C2H5O)2P(O)CH2CO2H
M. Pondus 196.14
Ferveret 150℃/0.05 mmHg (lit.)
Density 1.220 g/mL ad 25℃ (lit.)
Index refractivus n20/D 1.445 (lit.)
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Hyalina Liquid
Lepidium sativum (HPLC) Retentionis tempus summi culminis ex specimen consecutum est intra 5% of specimen referentis.
Puritas / Analysis Methodus >99.5% (HPLC)
Infrared Imaginis Conformat ut Structure
Proton NMR Spectrum Conformat ut Structure
Humor (KF) <0.50%
Totalis immunditias <0.50%
Test Standard Enterprise Standard
Consuetudinem Afatinib Dimaleate (CAS: 850140-73-7)

Sarcina & Repono:

sarcina: Fluorinated Utrem, 25kg/Drum, vel secundum exigentiam mos

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

1

FAQ:

Applicatio:

Diethylphosphonoaceticum acidum (CAS: 3095-95-2), Actus sicut nucleophilus ad additiones nucleophilicae reactiones pro synthesi allenae epoxidum Reactant pro: studiis Stereoselectivity Staudinger reaction;Formatio enantioselectiva diolorum per epoxidationem et hydropicos reactiones;Horner-Wadsworth-Emmonum profectae;Chelation remota regente Hiberniae-Claisen rearrangement;Ugi-Dieckmann reactiones ad synthesin derivationum acidi tetramici;Solebant phosphonoester intermedia facere ad motus intramoleculares HEW.Diethylphosphonoaceticum acidum medium ex Afatinib Dimaleate (CAS: 850140-73-7).Afatinib Dimaleate probatus est ab US Cibus et Drug Administration (FDA) in 2013 pro curatione cancri cellae non parvae (NSCLC).Speciatim probatum est aegris exhibere tumores metastaticos NSCLC, qui continent incrementum epidermalium receptorem (EGFR) exon deletionum vel exon 21 mutationum.Afatinib Dimaleate est covalens inhibitor of ErbB tyrosini kinases (tyk), quae gubernat ErbB significat immedicabile ligamen EGFR tyk sites ligandi.

Epistulam tuam hic scribe et mitte nobis